167 related articles for article (PubMed ID: 35617324)
1. Alprostadil for hypertensive nephropathy: A systematic review and meta-analysis of randomized controlled trials.
Fu H; Hou W; Zhang Y; Hu X
PLoS One; 2022; 17(5):e0269111. PubMed ID: 35617324
[TBL] [Abstract][Full Text] [Related]
2. Xuebijing injection combined with alprostadil in the treatment of diabetic nephropathy: A PRISMA-compliant systematic review and meta-analysis.
Hao N; Liu Y; Guo L; Li W; Zhao P
Medicine (Baltimore); 2024 Jun; 103(24):e32095. PubMed ID: 38875385
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and Safety of Sodium Tanshinone IIA Sulfonate Injection on Hypertensive Nephropathy: A Systematic Review and Meta-Analysis.
Xu J; Zhang C; Shi X; Li J; Liu M; Jiang W; Fang Z
Front Pharmacol; 2019; 10():1542. PubMed ID: 31920681
[No Abstract] [Full Text] [Related]
4. Combined therapy of hypertensive nephropathy with ginkgo leaf extract and dipyridamole injection and antihypertensive drugs: A systematic review and meta-analysis.
Jialiken D; Qian L; Ren S; Wu L; Xu J; Zou C
Medicine (Baltimore); 2021 May; 100(19):e25852. PubMed ID: 34106629
[TBL] [Abstract][Full Text] [Related]
5. Salvianolate injection for hypertensive nephropathy patients who were using valsartan: A systematic review and meta-analysis.
Xu Q; Shen Y; Zhao J; Shen J
Front Pharmacol; 2023; 14():1119150. PubMed ID: 36794275
[No Abstract] [Full Text] [Related]
6. Efficacy of Huangqi Injection in the Treatment of Hypertensive Nephropathy: A Systematic Review and Meta-Analysis.
Xu Z; Qian L; Niu R; Yang Y; Liu C; Lin X
Front Med (Lausanne); 2022; 9():838256. PubMed ID: 35547210
[TBL] [Abstract][Full Text] [Related]
7. The effect of alprostadil on preventing contrast-induced nephropathy for percutaneous coronary intervention in diabetic patients: A systematic review and meta-analysis.
Ye Z; Lu H; Guo W; Dai W; Li H; Yang H; Li L
Medicine (Baltimore); 2016 Nov; 95(46):e5306. PubMed ID: 27861357
[TBL] [Abstract][Full Text] [Related]
8. Shenkang injection combined with alprostadil for chronic renal failure: A systematic review and meta-analysis.
Xie F; Zhang T; Zhang P; Qu X; Li M; Lan W
Front Med (Lausanne); 2023; 10():982016. PubMed ID: 37089596
[TBL] [Abstract][Full Text] [Related]
9. Prevention of contrast-induced nephropathy with prostaglandin E1 in patients undergoing percutaneous coronary procedures: A meta-analysis of 24 randomized controlled trials
.
Liu X; Hang Y; Shen L; Yang J; Zhou L; Sha W; Lu G
Clin Nephrol; 2018 Nov; 90(5):313-324. PubMed ID: 30106366
[TBL] [Abstract][Full Text] [Related]
10. The Effects of Salvianolate Combined With Western Medicine on Diabetic Nephropathy: A Systematic Review and Meta-Analysis.
Shen Y; Wang S; Liu Y; Ge L; Xia L; Zhang X; Miao Y; Shen J; Zhou Q
Front Pharmacol; 2020; 11():851. PubMed ID: 32595500
[TBL] [Abstract][Full Text] [Related]
11. Traditional Chinese Medicine Injections Combined With Antihypertensive Drugs for Hypertensive Nephropathy: A Network Meta-Analysis.
Chen Z; Peng Y; Yang F; Qiang X; Chen Y; Chen Y; Cao L; Liu C; Zhang J
Front Pharmacol; 2021; 12():740821. PubMed ID: 34744724
[No Abstract] [Full Text] [Related]
12. Efficacy and Safety of Acupuncture in Renal Colic Caused by Urinary Calculi in Adults: A Systematic Review and Meta-Analysis.
Qu Z; Wang T; Tu J; Yao W; Pei X; Jia L; Cao Y; Liu C
Evid Based Complement Alternat Med; 2022; 2022():7140038. PubMed ID: 35832526
[TBL] [Abstract][Full Text] [Related]
13. Benefits of weight loss programs for breast cancer survivors: a systematic reviews and meta-analysis of randomized controlled trials.
Wang S; Yang T; Qiang W; Zhao Z; Shen A; Zhang F
Support Care Cancer; 2022 May; 30(5):3745-3760. PubMed ID: 35022884
[TBL] [Abstract][Full Text] [Related]
14. The effect of Chinese herbal medicine on hemorrhagic shock: A systematic review and meta-analysis.
Wang DL; Lu XG; Guo WX; Chen T; Song Y; Fan ZW
Complement Ther Med; 2016 Dec; 29():78-88. PubMed ID: 27912961
[TBL] [Abstract][Full Text] [Related]
15. [Network Meta-analysis of Huoxue Huayu Chinese medicine injections on hypertensive nephropathy].
Ya-Wei Z; Li-Fei WU; Yu-Hao Z; Li-Hua WU; Jie LI
Zhongguo Zhong Yao Za Zhi; 2020 Oct; 45(20):4997-5007. PubMed ID: 33350275
[TBL] [Abstract][Full Text] [Related]
16. Pentoxifylline for diabetic kidney disease.
Shan D; Wu HM; Yuan QY; Li J; Zhou RL; Liu GJ
Cochrane Database Syst Rev; 2012 Feb; (2):CD006800. PubMed ID: 22336824
[TBL] [Abstract][Full Text] [Related]
17. Effect of Alprostadil on the Prevention of Contrast-Induced Nephropathy: A Meta-Analysis of 36 Randomized Controlled Trials.
Xie J; Jiang M; Lin Y; Deng H; Li L
Angiology; 2019 Aug; 70(7):594-612. PubMed ID: 30669852
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of Jinshuibao as an adjuvant treatment for chronic renal failure in China: A meta-analysis.
Zhang H; Yuan C; Sun C; Zhang Q
Medicine (Baltimore); 2023 Aug; 102(32):e34575. PubMed ID: 37565918
[TBL] [Abstract][Full Text] [Related]
19. Should we add atorvastatin to irbesartan for improving renoprotective effects in early diabetic nephropathy? A meta-analysis of randomized controlled trials.
Zuo Y; Li T; Lei Z
Pharmacol Res; 2019 Aug; 146():104286. PubMed ID: 31152787
[TBL] [Abstract][Full Text] [Related]
20. Combination of
An X; Xu Y; Gui D
Evid Based Complement Alternat Med; 2023; 2023():2945234. PubMed ID: 37101717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
